Results 11 to 20 of about 1,421,260 (161)
Plexogenic pulmonary hypertension associated with POEMS syndrome
Respiratory Medicine Case Reports, 2017 Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome, occurring in approximately 25–30% of the affected individuals. However, the
Thomas Czeczok, Peter Lin, Eunhee Yi
doaj +2 more sources
Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry
Scientific ReportsPOEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein], and skin changes) is a rare systemic disorder characterized by various symptoms caused by underlying plasma cell (PC) dyscrasia.
Arata Ishii +20 more
doaj +2 more sources
A rare cause of pericardial effusion and ascites: POEMS syndrome [PDF]
Hematology Reports, 2017 POEMS syndrome is an important paraneoplastic syndrome associated with multisystem involvement. Extravascular volume overload like pericardial effusion and ascites has a broad differential diagnosis. In addition, it may be initial presentation of disease.
Bilal Katipoglu +5 more
doaj +2 more sources
Zdravniški Vestnik, 2008 BACKGROUND We have presented the patient with POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, M protein, Skin changes) in which peripheral neuropathy wasassociated with monoclonal gammopathy and osteosclerotic myeloma.
Bojana Luštrek, Peter Černelč
doaj +1 more source
POEMS Syndrome: Two Case Reports
Çukurova Üniversitesi Tıp Fakültesi Dergisi, 2015 Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is an uncommon condition related to a paraneoplastic syndrome secondary to an underlying plasma cell disorder.
Turgay Demir +3 more
doaj +3 more sources
Castleman disease variant of POEMS syndrome without M protein: a case report [PDF]
Frontiers in OncologyPOEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) syndrome is a paraneoplastic syndrome associated with an underlying plasma cell neoplasm. According to the current diagnostic criteria for POEMS syndrome, the presence
Min Ji +8 more
doaj +2 more sources
POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management. [PDF]
Am J HematolABSTRACT Disease Overview POEMS syndrome is a life‐threatening syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Dispenzieri A.
europepmc +2 more sources
, 2018 PURPOSE OF REVIEW: To provide an overview of polyneuropathy organomegaly endocrinopathy M-protein and skin changes (POEMS) syndrome, detailing new insights into pathogenesis, prognostic factors, treatments, and outcome scores.
Keddie, S, Lunn, MP
core +3 more sources
Update on the POEMS syndrome [PDF]
, 2022 POEMS syndrome is an acronym for polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. It is a rare paraneoplastic disorder related to plasma cell neoplasm. However, its pathophysiology has not yet been clearly elucidated.
김유리, Kim, Yu Ri, Yu Ri Kim
core +1 more source
Rasch-built overall disability scale for POEMS syndrome (POEMS-RODS) [PDF]
, 2022 Patient-reported outcome measures engage patients in disease severity measurement and the metrics reported can be meaningful to their lives. The Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome (POEMS) is a ...
Ryan Yann Shern Keh +15 more
core +3 more sources